GT Biopharma, Inc (GTBP)
| Market Cap | 213.38M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -52.35M |
| Shares Out | 33.52M |
| EPS (ttm) | -2.96 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 171,750 |
| Open | 7.31 |
| Previous Close | 7.43 |
| Day's Range | 6.99 - 7.43 |
| 52-Week Range | 3.90 - 19.73 |
| Beta | 1.57 |
| Analysts | Buy |
| Price Target | 25.33 (+261.9%) |
| Est. Earnings Date | Nov 12, 2021 |
About GTBP
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. The company develops various immuno-oncology product candidates, including GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I/II clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed acute myeloid leukemia or advanced sy...
Financial Performance
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for GT Biopharma stock is "Buy." The 12-month stock price forecast is 25.33, which is an increase of 261.86% from the latest price.
News
GT BioPharma's Next Generation Camelid TriKE® Nanobody Platform Highlighted at ESMO Congress 2021
BEVERLY HILLS, Calif., Sept. 20, 2021 /PRNewswire/ -- GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on t...
OXIS International Inc. (GTBP) Moves to Buy: Rationale Behind the Upgrade
OXIS International Inc. (GTBP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
GT Biopharma Announces Updated Positive Safety Data From Phase 1 GTB-3550 Monotherapy TriKE™ Trial an Investigational...
BEVERLY HILLS, Calif., Sept. 15, 2021 /PRNewswire/ -- GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on t...
GT Biopharma Advances GTB-3650, a Second-Generation Tri-Specific Killer Engager -TriKE®, Into IND-Enabling Studies
BEVERLY HILLS, Calif., Sept. 13, 2021 /PRNewswire/ -- GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on t...
GT Biopharma Announces Issuance of Two New Patents Covering TriKE® Platform Technologies
BEVERLY HILLS, Calif., Sept. 9, 2021 /PRNewswire/ -- GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on th...
GT Biopharma to Present at Upcoming September Investor Conferences
BEVERLY HILLS, Calif., Sept. 8, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's prop...
GT Biopharma Announces the Promotion of Dr. Gregory Berk to President of Research & Development and Chief Medical Off...
BEVERLY HILLS, Calif., Aug. 23, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's prop...
GT Biopharma Provides Second Quarter 2021 Business Update.
Announced Positive Interim Data Results Demonstrating Substantial Reduction in AML/MDS Cancer Cells… The post GT Biopharma Provides Second Quarter 2021 Business Update appeared first on Penny Stocks to ...
GT Biopharma Provides Second Quarter 2021 Business Update
BEVERLY HILLS, Calif., Aug. 13, 2021 /PRNewswire/ -- GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therap...
Former Penny Stocks To Watch After Merck's (MRK) Latest FDA Win
Merck's FDA and coronavirus vaccine news sparked momentum in biotech stocks today. Here are 4 to watch.
Hot Biotech Stocks That Deserve Your Attention In August 2021
Is it time to add biotech stocks to your list this year? The post Hot Biotech Stocks That Deserve Your Attention In August 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | Penny...
GT Biopharma to Host Conference Call to Discuss Second Quarter 2021 Results
BEVERLY HILLS, Calif., Aug. 6, 2021 /PRNewswire/ — GT Biopharma, Inc. (“GT… The post GT Biopharma to Host Conference Call to Discuss Second Quarter 2021 Results appeared first on Penny Stocks to Buy, Pi...
Are Penny Stocks Worth It? 5 That Deserve Your Attention Now
Have penny stocks presented some of the biggest opportunities in the stock market? The post Are Penny Stocks Worth It?
GT Biopharma Announces Positive Preclinical Results For GTB-5550 B7H3 TriKE™.
POTENTIAL TREATMENT OF SEVERAL SOLID TUMOR CANCERS INCLUDING: NON-SMALL CELL LUNG CANCER,… The post GT Biopharma Announces Positive Preclinical Results For GTB-5550 B7H3 TriKE™ appeared first on Penny S...
GT Biopharma Announces Positive Preclinical Results For GTB-5550 B7H3 TriKE™
BEVERLY HILLS, Calif., Aug. 3, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage biopharmaceutical company focused on developing target-directed, tri-specific Natural Killer (NK) ...
Former Biotech Penny Stocks Seeing Explosive Moves In 2021
Are penny stocks worth it? Take a look at these 3 seeing explosive moves this year.
3 Biotech Penny Stocks To Watch On Robinhood IPO Day
These Former Penny Stocks Are Turning Heads Ahead Of Robinhood IPO The post 3 Biotech Penny Stocks To Watch On Robinhood IPO Day appeared first on Penny Stocks to Buy, Picks, News and Information | Penn...
Top Biotech Stocks To Watch After Bristol Myers' Opdivo Sees Q2 Growth
Hot biotech stocks to watch right now as cancer treatments make headlines in 2021. The post Top Biotech Stocks To Watch After Bristol Myers' Opdivo Sees Q2 Growth appeared first on Penny Stocks to Buy, ...
GT Biopharma Announces $16 million in Warrant Exercise Proceeds.
Proceeds to Support GTBP Pipeline Drug Development Program BEVERLY HILLS, Calif., July… The post GT Biopharma Announces $16 million in Warrant Exercise Proceeds appeared first on Penny Stocks to Buy, Pi...
GT Biopharma Announces $16 million in Warrant Exercise Proceeds
BEVERLY HILLS, Calif., July 28, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (Tri...
3 Former Penny Stocks With Bullish Analysts & Price Targets Up To 120%
Former penny stocks biotech analysts are bullish on right now. The post 3 Former Penny Stocks With Bullish Analysts & Price Targets Up To 120% appeared first on Penny Stocks to Buy, Picks, News and Info...
3 Biotech Penny Stocks To Watch Seeing Explosive Gains In 2021
Are biotech penny stocks on your watch list in 2021? The post 3 Biotech Penny Stocks To Watch Seeing Explosive Gains In 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto...
Small-Cap Stocks To Watch After CYTK Sheds Spotlight On Biotech
Penny Stocks & Small Caps Jump As Biotech Industry Names Kick Into High Gear The post Small-Cap Stocks To Watch After CYTK Sheds Spotlight On Biotech appeared first on Penny Stocks to Buy, Picks, News a...
4 Hot Penny Stocks To Watch After The 1,100% SGOC Stock Rally
Are traders searching for penny stocks with certain technical traits like SGOC has? The post 4 Hot Penny Stocks To Watch After The 1,100% SGOC Stock Rally appeared first on Penny Stocks to Buy, Picks, N...
3 Former Penny Stocks To Watch This Week As Earnings Season Kicks Off
Why Focus On Penny Stocks? Here Are A Few That Give A Great Answer To That Question.